Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Lessard JA, Crabtree GR. Chromatin regulatory mechanisms in pluripotency. Annu. Rev. Cell Dev. Biol.26,503–532 (2010).
  Medline CASGoogle Scholar
• 2  Mills AA. Throwing the cancer switch. reciprocal roles of polycomb and trithorax proteins. Nat. Rev. Cancer10(10),669–682 (2010).
  Medline CASGoogle Scholar
• 3  Ringrose L, Paro R. Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins. Annu. Rev. Genet.38,413–443 (2004).
  Medline CASGoogle Scholar
• 4  Soshnikova N, Duboule D. Epigenetic regulation of vertebrate Hox genes: a dynamic equilibrium. Epigenetics4(8),537–540 (2009).
  Medline CASGoogle Scholar
• 5  Mallo M, Wellik DM, Deschamps J. Hox genes and regional patterning of the vertebrate body plan. Dev. Biol.344(1),7–15 (2010).
  Medline CASGoogle Scholar
• 6  Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat. Rev. Cancer10(5),361–371 (2010).
  Medline CASGoogle Scholar
• 7  Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature445(7124),214–218 (2007).▪▪ Dissects the function of H3 arginine methyltransferase in cell fate determination of a four-cell stage mouse embryo.
  Medline CASGoogle Scholar
• 8  Wu Q, Bruce AW, Jedrusik A et al. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation. Stem Cells27(11),2637–2645 (2009).
  Medline CASGoogle Scholar
• 9  Parfitt DE, Zernicka-Goetz M. Epigenetic modification affecting expression of cell polarity and cell fate genes to regulate lineage specification in the early mouse embryo. Mol. Biol. Cell21(15),2649–2660 (2010).
  Medline CASGoogle Scholar
• 10  O’neill LP, Vermilyea MD, Turner BM. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nat. Genet.38(7),835–841 (2006).
  MedlineGoogle Scholar
• 11  Ang YS, Tsai SY, Lee DF et al. Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell145(2),183–197 (2011).
  Medline CASGoogle Scholar
• 12  Dou Y, Milne TA, Ruthenburg AJ et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat. Struct. Mol. Biol.13(8),713–719 (2006).
  Medline CASGoogle Scholar
• 13  Boyer LA, Plath K, Zeitlinger J et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature441(7091),349–353 (2006).
  Medline CASGoogle Scholar
• 14  Conerly MI, Macquarrie KL, Fong AP, Yao Z, Tapscott SJ. Polycomb-mediated repression during terminal differentiation: what don’t you want to be when you grow up? Genes Dev.25(10),997–1003 (2011).
  Medline CASGoogle Scholar
• 15  Lee TI, Jenner RG, Boyer LA et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell125(2),301–313 (2006).
  Medline CASGoogle Scholar
• 16  Lee MG, Villa R, Trojer P et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science318(5849),447–450 (2007).
  Medline CASGoogle Scholar
• 17  Agger K, Cloos PA, Christensen J et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature449(7163),731–734 (2007).
  Medline CASGoogle Scholar
• 18  Lan F, Bayliss PE, Rinn JL et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature449(7163),689–694 (2007).
  Medline CASGoogle Scholar
• 19  Peng JC, Valouev A, Swigut T et al. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell139(7),1290–1302 (2009).
  MedlineGoogle Scholar
• 20  Pasini D, Cloos PA, Walfridsson J et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature464(7286),306–310 (2010).
  Medline CASGoogle Scholar
• 21  Shen X, Kim W, Fujiwara Y et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell139(7),1303–1314 (2009).
  MedlineGoogle Scholar
• 22  Endoh M, Endo TA, Endoh T et al. Polycomb group proteins Ring1A/B are functionally linked to the core transcriptional regulatory circuitry to maintain ES cell identity. Development135(8),1513–1524 (2008).
  Medline CASGoogle Scholar
• 23  Stock JK, Giadrossi S, Casanova M et al. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat. Cell Biol.9(12),1428–1435 (2007).
  Medline CASGoogle Scholar
• 24  Alder O, Lavial F, Helness A et al. Ring1B and Suv39h1 delineate distinct chromatin states at bivalent genes during early mouse lineage commitment. Development137(15),2483–2492 (2010).
  Medline CASGoogle Scholar
• 25  Loh YH, Zhang W, Chen X, George J, Ng HH. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev.21(20),2545–2557 (2007).
  Medline CASGoogle Scholar
• 26  Feldman N, Gerson A, Fang J et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol.8(2),188–194 (2006).
  Medline CASGoogle Scholar
• 27  Epsztejn-Litman S, Feldman N, Abu-Remaileh M et al.De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol.15(11),1176–1183 (2008).
  Medline CASGoogle Scholar
• 28  Szutorisz H, Canzonetta C, Georgiou A, Chow CM, Tora L, Dillon N. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Mol. Cell Biol.25(5),1804–1820 (2005).
  Medline CASGoogle Scholar
• 29  Pasini D, Malatesta M, Jung HR et al. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res.38(15),4958–4969 (2010).
  Medline CASGoogle Scholar
• 30  Yao TP, Oh SP, Fuchs M et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell93(3),361–372 (1998).
  Medline CASGoogle Scholar
• 31  Xu CR, Cole PA, Meyers DJ, Kormish J, Dent S, Zaret KS. Chromatin ‘prepattern’ and histone modifiers in a fate choice for liver and pancreas. Science332(6032),963–966 (2011).▪▪ Highlights the importance of chromatin patterns in the fate decision between liver and pancreas by isolating ventral foregut endoderm cells from mouse embryos.
  Medline CASGoogle Scholar
• 32  Ma P, Schultz RM. Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos. Dev. Biol.319(1),110–120 (2008).
  Medline CASGoogle Scholar
• 33  Brunmeir R, Lagger S, Seiser C. Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int. J. Dev. Biol.53(2–3),275–289 (2009).
  Medline CASGoogle Scholar
• 34  Kaji K, Nichols J, Hendrich B. Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells. Development134(6),1123–1132 (2007).
  Medline CASGoogle Scholar
• 35  Marino S, Nusse R. Mutants in the mouse NuRD/Mi2 component P66α are embryonic lethal. PLoS ONE2(6),e519 (2007).
  MedlineGoogle Scholar
• 36  Zhu D, Fang J, Li Y, Zhang J. Mbd3, a component of NuRD/Mi-2 complex, helps maintain pluripotency of mouse embryonic stem cells by repressing trophectoderm differentiation. PLoS ONE4(11),e7684 (2009).
  MedlineGoogle Scholar
• 37  Liang J, Wan M, Zhang Y et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol.10(6),731–739 (2008).
  Medline CASGoogle Scholar
• 38  Dovey OM, Foster CT, Cowley SM. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc. Natl Acad. Sci. USA107(18),8242–8247 (2010).
  Medline CASGoogle Scholar
• 39  Lyu J, Jho EH, Lu W. Smek promotes histone deacetylation to suppress transcription of Wnt target gene brachyury in pluripotent embryonic stem cells. Cell Res.21(6),911–921 (2011).
  Medline CASGoogle Scholar
• 40  Addis RC, Prasad MK, Yochem RL et al. OCT3/4 regulates transcription of histone deacetylase 4 (Hdac4) in mouse embryonic stem cells. J. Cell Biochem.111(2),391–401 (2010).
  Medline CASGoogle Scholar
• 41  Montgomery RL, Davis CA, Potthoff MJ et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev.21(14),1790–1802 (2007).
  Medline CASGoogle Scholar
• 42  Trivedi CM, Luo Y, Yin Z et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity. Nat. Med.13(3),324–331 (2007).
  Medline CASGoogle Scholar
• 43  Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ. Distribution of histone deacetylases 1–11 in the rat brain. J. Mol. Neurosci.31(1),47–58 (2007).
  Medline CASGoogle Scholar
• 44  Akhtar MW, Raingo J, Nelson ED et al. Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. J. Neurosci.29(25),8288–8297 (2009).
  Medline CASGoogle Scholar
• 45  Quinti L, Chopra V, Rotili D et al. Evaluation of histone deacetylases as drug targets in Huntington’s disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model. PLoS Curr.2,pii: RRN1172 (2010).
  MedlineGoogle Scholar
• 46  Helmlinger D, Hardy S, Eberlin A, Devys D, Tora L. Both normal and polyglutamine-expanded ataxin-7 are components of TFTC-type GCN5 histone acetyltransferase – containing complexes. Biochem. Soc. Symp.73,155–163 (2006).
  CASGoogle Scholar
• 47  Mcmahon SJ, Pray-Grant MG, Schieltz D, Yates JR 3rd, Grant PA. Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. Proc. Natl Acad. Sci. USA102(24),8478–8482 (2005).
  Medline CASGoogle Scholar
• 48  Palhan VB, Chen S, Peng GH et al. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc. Natl Acad. Sci. USA102(24),8472–8477 (2005).
  Medline CASGoogle Scholar
• 49  David G, Abbas N, Stevanin G et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat. Genet.17(1),65–70 (1997).
  Medline CASGoogle Scholar
• 50  David G, Durr A, Stevanin G et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum. Mol. Genet.7(2),165–170 (1998).
  Medline CASGoogle Scholar
• 51  Chen YC, Gatchel JR, Lewis RW et al. Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model. Hum. Mol. Genet.21(2),394–405 (2012).
  Medline CASGoogle Scholar
• 52  Caretti G, Di Padova M, Micales B, Lyons Ge, Sartorelli V. The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev.18(21),2627–2638 (2004).
  Medline CASGoogle Scholar
• 53  Rampalli S, Li L, Mak E et al. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat. Struct. Mol. Biol.14(12),1150–1156 (2007).
  Medline CASGoogle Scholar
• 54  Acharyya S, Sharma SM, Cheng AS et al. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy. PLoS ONE5(8),e12479 (2010).
  MedlineGoogle Scholar
• 55  Chen H, Gu X, Su IH et al. Polycomb protein Ezh2 regulates pancreatic β-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev.23(8),975–985 (2009).
  Medline CASGoogle Scholar
• 56  Dhawan S, Tschen SI, Bhushan A. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic β-cell proliferation. Genes Dev.23(8),906–911 (2009).
  Medline CASGoogle Scholar
• 57  Ezhkova E, Pasolli HA, Parker JS et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell136(6),1122–1135 (2009).
  Medline CASGoogle Scholar
• 58  Leung C, Lingbeek M, Shakhova O et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature428(6980),337–341 (2004).
  Medline CASGoogle Scholar
• 59  Roman-Trufero M, Mendez-Gomez HR, Perez C et al. Maintenance of undifferentiated state and self-renewal of embryonic neural stem cells by Polycomb protein Ring1B. Stem Cells27(7),1559–1570 (2009).
  Medline CASGoogle Scholar
• 60  Sher F, Rossler R, Brouwer N, Balasubramaniyan V, Boddeke E, Copray S. Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells26(11),2875–2883 (2008).
  Medline CASGoogle Scholar
• 61  Pasini D, Bracken AP, Hansen JB, Capillo M, Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell Biol.27(10),3769–3779 (2007).
  Medline CASGoogle Scholar
• 62  Hirabayashi Y, Suzki N, Tsuboi M et al. Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition. Neuron63(5),600–613 (2009).
  Medline CASGoogle Scholar
• 63  Luna-Fineman S, Shannon KM, Lange BJ. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood85(8),1985–1999 (1995).
  Medline CASGoogle Scholar
• 64  Dohner K, Brown J, Hehmann U et al. Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders. Blood92(11),4031–4035 (1998).
  Medline CASGoogle Scholar
• 65  Iwase S, Lan F, Bayliss P et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell128(6),1077–1088 (2007).
  Medline CASGoogle Scholar
• 66  Kleine-Kohlbrecher D, Christensen J, Vandamme J et al. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol. Cell38(2),165–178 (2010).
  Medline CASGoogle Scholar
• 67  Van Bokhoven H, Kramer JM. Disruption of the epigenetic code. an emerging mechanism in mental retardation. Neurobiol. Dis.39(1),3–12 (2010).
  Medline CASGoogle Scholar
• 68  Shima Y, Kitabayashi I. Deregulated transcription factors in leukemia. Int. J. Hematol.94(2),134–141 (2011).
  Medline CASGoogle Scholar
• 69  Kobelka CE. Exome sequencing: expanding the genetic testing toolbox. Clin. Genet.78(2),132–134 (2010).
  Medline CASGoogle Scholar
• 70  Cooper GM, Shendure J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet.12(9),628–640 (2011).
  Medline CASGoogle Scholar
• 71  Bamshad MJ, Ng SB, Bigham AW et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet.12(11),745–755 (2011).▪ Discusses the advantages and limitations of using exome sequencing to define causative mutations underlying genetic diseases.
  Medline CASGoogle Scholar
• 72  Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat. Med.10(8),789–799 (2004).
  Medline CASGoogle Scholar
• 73  Liu H, Cheng EH, Hsieh JJ. MLL fusions: pathways to leukemia. Cancer Biol. Ther.8(13),1204–1211 (2009).
  Medline CASGoogle Scholar
• 74  Marschalek R. Mechanisms of leukemogenesis by MLL fusion proteins. Br. J. Haematol.152(2),141–154 (2010).
  MedlineGoogle Scholar
• 75  Guenther MG, Lawton LN, Rozovskaia T et al. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev.22(24),3403–3408 (2008).
  Medline CASGoogle Scholar
• 76  Morin RD, Mendez-Lago M, Mungall AJ et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature476(7360),298–303 (2011).
  Medline CASGoogle Scholar
• 77  Pasqualucci L, Trifonov V, Fabbri G et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet.43(9),830–837 (2011).
  Medline CASGoogle Scholar
• 78  Hess JL, Yu BD, Li B, Hanson R, Korsmeyer SJ. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood90(5),1799–1806 (1997).
  Medline CASGoogle Scholar
• 79  Heuser M, Yap DB, Leung M et al. Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation. Blood113(7),1432–1443 (2009).
  Medline CASGoogle Scholar
• 80  Velichutina I, Shaknovich R, Geng H et al. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood116(24),5247–5255 (2010).
  Medline CASGoogle Scholar
• 81  Chase A, Cross NC. Aberrations of EZH2 in cancer. Clin. Cancer Res.17(9),2613–2618 (2011).
  Medline CASGoogle Scholar
• 82  Morin RD, Johnson NA, Severson TM et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet.42(2),181–185 (2010).
  Medline CASGoogle Scholar
• 83  Yap DD, Chu J, Berg T et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood117(8),2451–2459 (2011).
  Medline CASGoogle Scholar
• 84  Makishima H, Jankowska AM, Tiu RV et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia24(10),1799–1804 (2010).
  Medline CASGoogle Scholar
• 85  Nikoloski G, Langemeijer SM, Kuiper RP et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet.42(8),665–667 (2010).
  Medline CASGoogle Scholar
• 86  Ernst T, Chase AJ, Score J et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet.42(8),722–726 (2010).
  Medline CASGoogle Scholar
• 87  Jankowska AM, Makishima H, Tiu RV et al. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2 and DNMT3A. Blood118(14),3932–3941 (2011).
  Medline CASGoogle Scholar
• 88  Grossmann V, Kohlmann A, Eder C et al. Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance. Leukemia25(5),877–879 (2011).
  Medline CASGoogle Scholar
• 89  Van Haaften G, Dalgliesh GL, Davies H et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet.41(5),521–523 (2009).
  Medline CASGoogle Scholar
• 90  Chapman MA, Lawrence MS, Keats JJ et al. Initial genome sequencing and analysis of multiple myeloma. Nature471(7339),467–472 (2011).
  Medline CASGoogle Scholar
• 91  Stec I, Wright TJ, Van Ommen GJ et al. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf–Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum. Mol. Genet.7(7),1071–1082 (1998).
  Medline CASGoogle Scholar
• 92  Martinez-Garcia E, Popovic R, Min DJ et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood117(1),211–220 (2011).
  Medline CASGoogle Scholar
• 93  Mullighan CG, Zhang J, Kasper LH et al.CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature471(7337),235–239 (2011).
  Medline CASGoogle Scholar
• 94  Pasqualucci L, Dominguez-Sola D, Chiarenza A et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature471(7337),189–195 (2011).▪ Reports inactivating mutations in the histone acetyltransferases CREBBP and EP300, and loss of CBP acetyltransferase function toward its nonhistone substrates, p53 and BCL6.
  Medline CASGoogle Scholar
• 95  Oike Y, Takakura N, Hata A et al. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood93(9),2771–2779 (1999).
  Medline CASGoogle Scholar
• 96  Parsons DW, Li M, Zhang X et al. The genetic landscape of the childhood cancer medulloblastoma. Science331(6016),435–439 (2011).▪▪ First report implicating MLL2 and MLL3 as tumor suppressors in pediatric medulloblastoma.
  Medline CASGoogle Scholar
• 97  Northcott PA, Nakahara Y, Wu X et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat. Genet.41(4),465–472 (2009).
  Medline CASGoogle Scholar
• 98  Gui Y, Guo G, Huang Y et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat. Genet.43(9),875–878 (2011).
  Medline CASGoogle Scholar
• 99  Dalgliesh GL, Furge K, Greenman C et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature463(7279),360–363 (2010).
  Medline CASGoogle Scholar
• 100  Varela I, Tarpey P, Raine K et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature469(7331),539–542 (2011).
  Medline CASGoogle Scholar
• 101  Petrij F, Giles RH, Dauwerse HG et al. Rubinstein–Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature376(6538),348–351 (1995).
  Medline CASGoogle Scholar
• 102  Roelfsema JH, Peters DJ. Rubinstein–Taybi syndrome: clinical and molecular overview. Expert Rev. Mol. Med.9(23),1–16 (2007).
  MedlineGoogle Scholar
• 103  De Sario A. Clinical and molecular overview of inherited disorders resulting from epigenomic dysregulation. Eur. J. Med. Genet.52(6),363–372 (2009).
  MedlineGoogle Scholar
• 104  Alarcon JM, Malleret G, Touzani K et al. Chromatin acetylation, memory, and LTP are impaired in CBP^+/- mice: a model for the cognitive deficit in Rubinstein–Taybi syndrome and its amelioration. Neuron42(6),947–959 (2004).
  Medline CASGoogle Scholar
• 105  Bartholdi D, Roelfsema JH, Papadia F et al. Genetic heterogeneity in Rubinstein–Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300. J. Med. Genet.44(5),327–333 (2007).
  Medline CASGoogle Scholar
• 106  Miller RW, Rubinstein JH. Tumors in Rubinstein–Taybi syndrome. Am. J. Med. Genet.56(1),112–115 (1995).
  Medline CASGoogle Scholar
• 107  Kleefstra T, Smidt M, Banning MJ et al. Disruption of the gene Euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J. Med. Genet.42(4),299–306 (2005).
  Medline CASGoogle Scholar
• 108  Verhoeven WM, Egger JI, Vermeulen K, Van De Warrenburg BP, Kleefstra T. Kleefstra syndrome in three adult patients: further delineation of the behavioral and neurological phenotype shows aspects of a neurodegenerative course. Am. J. Med. Genet. A155(10),2409–2415 (2011).
  CASGoogle Scholar
• 109  Cheung HC, Yatsenko SA, Kadapakkam M et al. Constitutional tandem duplication of 9q34 that truncates EHMT1 in a child with ganglioglioma. Pediatr. Blood Cancer58(5),801–805 (2012).
  MedlineGoogle Scholar
• 110  Jensen LR, Amende M, Gurok U et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet.76(2),227–236 (2005).
  Medline CASGoogle Scholar
• 111  Rujirabanjerd S, Nelson J, Tarpey PS et al. Identification and characterization of two novel JARID1C mutations: suggestion of an emerging genotype-phenotype correlation. Eur. J. Hum. Genet.18(3),330–335 (2010).
  Medline CASGoogle Scholar
• 112  Tahiliani M, Mei P, Fang R et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature447(7144),601–605 (2007).
  Medline CASGoogle Scholar
• 113  Ng SB, Bigham AW, Buckingham KJ et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet.42(9),790–793 (2010).▪▪ Reports that mutations in MLL2 cause Kabuki syndrome. This is the first example in which mutations within an MLL family member play a causal role in a multiple malformation disorder.
  Medline CASGoogle Scholar
• 114  Paulussen AD, Stegmann AP, Blok MJ et al.MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum. Mutat.32(2),E2018–E2025 (2010).
  MedlineGoogle Scholar
• 115  Hannibal MC, Buckingham KJ, Ng SB et al. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am. J. Med. Genet. A155A(7),1511–1516 (2011).
  MedlineGoogle Scholar
• 116  Li Y, Bogershausen N, Alanay Y et al. A mutation screen in patients with Kabuki syndrome. Hum. Genet.130(6),715–724 (2011).
  Medline CASGoogle Scholar
• 117  Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J. Pediatr.99(4),565–569 (1981).
  Medline CASGoogle Scholar
• 118  Kuroki Y, Suzuki Y, Chyo H, Hata A, Matsui I. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J. Pediatr.99(4),570–573 (1981).
  Medline CASGoogle Scholar
• 119  Pless B, Oehm C, Knauer S, Stauber RH, Dingermann T, Marschalek R. The heterodimerization domains of MLL-FYRN and FYRC – are potential target structures in t(4;11) leukemia. Leukemia25(4),663–670 (2011).
  Medline CASGoogle Scholar